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A widespread outbreak of avian influenza throughout
East Asia and the ability of these avian viruses to trans-
fer to humans and cause severe infection have raised
concerns that such infections could lead to another
pandemic of the disease [1]. Antiviral drugs that are
effective against such infections hold great promise as
means to control these viruses. However, their cost and
limited supply may limit their widespread use. The
broad-spectrum antiviral drug ribavirin was shown to
inhibit influenza-A virus (IAV) and B virus infections
in animal models [2–4], but some adverse reactions
have been observed in clinical trials with this drug [5].
The administration of ribavirin is limited to a rela-
tively narrow therapeutic range because high doses
can induce hemolytic anemia, and excessive doses
may exert teratogenic effects [5,6].
In recent years, many researchers have focused on
the discovery and development of innovative antiviral
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High-performance liquid chromatography coupled with an ultraviolet detector was used to quanti-
tatively determine the amount of caffeoylquinic acid, arctium lappa glycoside, aurantiamarin and
forsythin present in five solvent extracts (water, 30% ethanol, 50% ethanol, 70% ethanol and 95%
ethanol) of Yinqiaosan (YQS). The calibration curves of the four components were linear
(r2 > 0.998) over the concentration range of 0.9–151.5 μg/mL. This method showed good repeata-
bility with relative standard deviations of less than 2.9% and mean recoveries of 91.3–100.5%. We
established the relative amounts of each of the four main ingredients in YQS for all five solvent
extracts. The direct inhibitory effects of the five YQS extracts on influenza-A virus in vitro and the
therapeutic effects on infected embryonated hen eggs were evaluated. YQS extracted in 50% ethanol
and used at concentrations of 500mg/mL and 250mg/mL exerted the greatest therapeutic effect in
infected embryonated hen eggs and was significantly superior to ribavirin (p < 0.05). Therefore,
the 50% ethanol extract of YQS seems to be the most effective for the inhibition of influenza-A
virus. Based on these results, further studies are warranted to evaluate the use of YQS extracts as
a possible therapy for influenza.
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drugs to treat influenza. Since Traditional Chinese
Medicine (TCM) has been used to treat diseases in
China for thousands of years, many research insti-
tutes have focused on TCM because of their efficacy
and low toxicity [7,8]. Today, the use of TCM as com-
plementary or alternative medicines is burgeoning
globally, including developed countries. Meanwhile,
over 80% of the population in developing countries
mainly depend on traditional healing modalities, in-
cluding herbal remedies, for maintaining good health
and to treat disease [9,10].
The classical formula Yinqiaosan (YQS) was first
documented in the book “Wen Bing Tiao Bian,” which
records the theoretical research on warm-heat disease
in TCM and its clinical application in the Chinese his-
tory. YQS consists of nine herbal components, namely:
Flos lonicerae (Jinyinhua), Fructus forsythiae (Lianqiao),
Fructus arctii (Niubangzi), Herba schizonepetae
(Jingjie), Herba menthae (Bohe), Semen sojae praepara-
tum (Dandochi), Herba lophatheri (Zhuye), Rhizoma
phragmitis (Lugen), and Radix glycyrrhizae (Gan cao).
This formula and its modified variations have a
lengthy history for the treatment of the common cold,
fever, coughing, and other respiratory diseases [11].
A formula comprised of 11 herbs may sound fairly
complicated, and thus a simplified formula containing
fewer components may be more convenient and more
popular in clinical use. Previous studies have demon-
strated that YQS inhibits the replication of IAV when
administered simultaneously with exposure to IAV, or
when YQS is administered during the advanced stage
of disease, to treat pneumonia induced in mice by IAV.
YQS reduced the lung index and death rate in mice,
thus improving their life expectancy [12,13]. The
extracts of Flos lonicerae, Fructus forsythiae, and Fructus
arctii could down-regulate the expression of Fas, Fasl,
tumor necrosis factor-α and tumor necrosis factor
receptor-I mRNA in mice with pneumonia induced by
influenza virus, and inhibited apoptosis of pneumonic
tissue cells [14]. It is well known that the therapeutic
effects of herbal medicines are based on the synergistic
actions of their main constituents [15,16]. Therefore, in
this study, we focused on caffeoylquinic acid, arctium
lappa glycoside, aurantiamarin, and forsythin, being
the main active components of Flos lonicerae, Fructus
arctii, Fructus forsythiae, and Herba schizonepetae, respec-
tively, to evaluate the quality and standardization of
the four herbs and their preparations [17,18]. Multiple
compound determination has been developed to study
the quality of such formulae by simultaneously eval-
uating many active compounds from different herbs
in prescriptions [19].
The fingerprinting of TCM product extracts
reflects the chemical composition of each herb in the
formula, or the distribution of the chemical composi-
tion and its content after herbs re-constituting in
quantities and dosage. Furthermore, detailed informa-
tion about whether the components are complete or
not can be determined. At present, using information
such as the chromatogram peak location, area size
and distribution, studies of the fingerprint of TCM can
reveal their chemical compositions and pharmacody-
namic properties. Presently, the research on Chinese
herbal formula fingerprints was in the primary stage,
especially the study on the combination of Yinqiaosan
fingerprints and pharmacodynamics was scarcely rare
[20–22]. Therefore, we sought to establish the finger-
print of YQS and how this was related to its anti-IAV
effects.
To achieve this, we evaluated the relative abun-
dance of four key components of YQS in five solvent
extracts (water, 30% ethanol, 50% ethanol, 70% ethanol,
and 95% ethanol) and compared the IAV-inhibitory
effects of these extracts with that of ribavirin in vitro.
MATERIALS AND METHODS
Reagents and plant material
High-performance liquid chromatography (HPLC)-
grade methanol (Tedia, Fairfield, OH, USA) and other
analytical-grade reagents were purchased from KaiXin
Chemical Industry Company (Tianjin, China). Milli-Q
water (Millipore, Billerica, MA, USA) was used to
prepare all the solutions. The reference compounds
caffeoylquinic acid, arctium lappa glycoside, aurantia-
marin, and forsythin were purchased from The
National Institute for the Control of Pharmaceutical
and Biological Products (Beijing, China). The purity
of each standard was over 98% and was suitable for
HPLC determination.
The medicinal plants Flos lonicerae, Fructus forsythiae,
Fructus arctii, and Herba schizonepetae were purchased
from the dispensary of Liaoning University of TCM
(Shenyang, China) and identified by Dr Xixiang Ying.
Voucher specimens are maintained at The Affiliated
Hospital of Liaoning University of TCM (Shenyang,
China).
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Compounds and viruses
Ribavirin was provided by WuZhong Pharmaceuti-
cals Inc. (Batch no. 080615, Jiangsu, China) and 9 day-
old embryonated chicken eggs were purchased from
YiKang Biological Pharmaceuticals Inc. (Liaoyang,
China).
Influenza A/FM1/7 (H1N1) was obtained from The
Center for Disease Control and Prevention (Beijing,
China). The virus used in the experiments was prop-
agated in the chorioallantoic cavities of 9-day old
embryonated chicken eggs for 3 days at 35°C. The
infected allantoic fluids were then centrifuged at
1,000g for 20 minutes and stored as the virus stock
solution at −80°C. Samples of the frozen virus was
thawed rapidly when needed and diluted with serum-
free E-MEM at dilutions ranging from 10–1 to 10–12.
Flat-bottomed, 96-well microplates were used for 
in vitro antiviral experiments and virus titrations.
Apparatus and chromatographic 
conditions
Analyses were performed on an Agilent Series 1100
HPLC with an ultraviolet detector. All separations
were carried out on a Phenomsil ODS C18 column
[250 × 4.6 mm; inner diameter (i.d.), 5 μm] (Tianjing,
China). The mobile phase consisted of methanol (M)
and 4% phosphoric acid solution (P) in a gradient
elution mode, which was carried out as follows: 0–5
minutes, linear gradient from M:P [2:98 (v/v)] to M:P
(4:96, v/v); 5–10 minutes, mobile phase from M:P
(4:96, v/v) to M:P (17:83, v/v); 10–20 minutes, linear
gradient to M:P (30:70, v/v); 20–30 minutes, linear gra-
dient to M:P (40:60, v/v); 30–45 minutes, linear gradi-
ent to M:P (44:56, v/v); 45–55 minutes, linear gradient
to M:P (55:45, v/v); 55–60 minutes, linear gradient to
M:P (60:40, v/v). Each run was followed by an equili-
bration time of 15 minutes. Ultraviolet spectra were
monitored at 275 nm, and the flow rate was 1.0 mL/
min. The data were collected and analyzed using
Chemstation software (Agilent Technologies Co. Ltd.,
USA).
Preparation of sample solutions
Flos lonicerae, Fructus forsythiae, Fructus arctii, and Herba
schizonepetae were ground and mixed. The powder
mixture (0.5g) was weighed and extracted with 20mL
methanol in an ultrasonic water bath (Shanghai
Kudos Ultrasonic Instrument Co., Shanghai, China)
for 40 minutes. The supernatant was filtered through
a 0.45-μm membrane filter and used directly for
HPLC analysis.
Method validation
Linearity, precision, repeatability, stability, and recov-
ery were carried out to validate the HPLC method.
Determination of the 50% egg infectious
dose (EID50)
The IAV stock solution at dilutions ranging from 10–1 to
10–12 was inoculated into the chorioallantoic cavities
of 9 day-old embryonated chicken eggs. Each concen-
tration was inoculated into four embryonated chicken
eggs with isotonic NaCl as a control, and incubated
at 33–35°C for 48 hours, followed by 4°C for 12 hours.
The chorioallantoic cavities were then collected and
placed in the flat-bottomed microplates with chicken
red blood cells, mixed gently, and then left to stand
for 40 minutes. The EID50 was then calculated using the
Kärbe formula and was used to determine the starting
concentration of virus solution. In this study, we used
the 100EID50 [23].
Determination of maximum (0%) toxic 
dose (TD0)
Isotonic NaCl containing 10% penicillin and strepto-
mycin (PS) was used to dilute the herb stock solution
at serial concentrations (from stock solution to 1/512).
Then, 0.2 mL was added to the embryonated chicken
eggs. Each concentration of herb solution was inocu-
lated into four embryonated chicken eggs with isotonic
NaCl as a control. The eggs were incubated at 37°C
for 48 hours and observed for survival at 12-hour
intervals. Embryonated chicken eggs that died within
24 hours were not included in the herbal toxicity
analysis.
Determination of the maximum non-blood
clotting concentration
Isotonic NaCl containing 0.9% PS was used to dilute
the herb stock solution at six concentrations [2 × 10–7
to 2 × 10–1 (7.8 mg/mL to 500 mg/mL)] with double
dilution and placed on flat-bottomed microplates.
Each concentration was titrated into two cribriform
foramina with isotonic NaCl as a control. Then, 1%
chicken red blood cell solution was placed into each
cribriform foramina. The flat-bottomed microplates
were then incubated at 33–35°C for 2 hours to deter-
mine the hemagglutination titer.
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Time-dependent in vitro IAV-inhibitory
effects of the five YQS extracts
Isotonic NaCl containing 0.9% PS was used to dilute
the herb stock solution to the maximum non-blood
clotting concentration, using the appropriate IAV solu-
tion with ribavirin and Hank’s solution for compari-
son. Each preparation (four samples per group) was
incubated at 33–35°C for 1, 6, 12, 18, or 24 hours, to
determine the time-dependent effect of each sample
on hemagglutination.
Evaluation of the therapeutic effect 
of YQS extracts on embryonated chicken
eggs infected by IAV
The 100 EID50 viral suspension was used to inoculate
eight embryonated chicken eggs and incubated for 
2 hours at 37°C. Then, the herb stock solution was in-
oculated at three concentrations with double dilution
(stock solution, 2×10–2 and 2×10–1); isotonic NaCl and
ribavirin were used as a control and active comparator.
The samples were incubated for 48 hours at 34°C and
then for 12 hours at 4°C. The chorioallantoic cavities
were collected and placed in flat-bottomed microplates
with 0.1mL of chicken red blood cells, mixed gently
and left to stand for 40 minutes to observe the hemag-
glutination titer.
Assessment of the hemagglutination titer
Hemagglutination titer was assessed as previously
described [23]. Briefly, the titer was rated as ++++,
+++, ++, + or −, where: ++++ indicates that the red
blood cells were distributed uniformly on the cribriform
foramina of the 96-well flat-bottomed microplates;
+++ is similar to ++++, but the borders of red cell clots
were irregular and the area of distribution was smaller;
++ indicates that red cells formed a ring with small
clumps at the edge of the cribriform foramina; + indi-
cates that the red cells had formed small clumps, but
the borders were not smooth, and small clumps were
found at the edge of the cribriform foramina; – indi-
cates that the red blood cells had formed small
clumps in the bottom of the cribriform foramina and
the borders were smooth and stereoscopic, and tilting
the flat-bottomed microplates caused the red blood
cells to form tear shapes.
The hemagglutination titer was calculated as fol-
lows. ++ represents one agglutination unit and is the
highest concentration of the virus that caused hema-
gglutination and was used as the end-point of the
assays. The reciprocal of this concentration is the
hemagglutination titer. If the end-points are ++++ or
+++, they were calculated after data arrangement.
Statistical analysis
SPSS version 11.5 (SPSS Inc., Chicago, IL, USA) was
used for data analysis. Continuous data are shown 
as mean ± standard deviation and were analyzed by
one-factor analysis of variance. Post hoc analyses were
performed using the Least Squares Difference method.
RESULTS
Method validation
The calibration curves for caffeoylquinic acid, auran-
tiamarin, arctium lappa glycoside and forsythin were
prepared for the concentration ranges of 1.89–189
μg/mL, 3.04–30.4 μg/mL, 5.05–151.5 μg/mL and
0.93–22.32 μg/mL, respectively. The regression equa-
tions (regression coefficients) were: y = 15.772x +
45.951 (r = 0.9986), y = 25.231x + 31.844 (r = 0.9992), y =
5.4413x + 28.258 (r = 0.9983), and y = 11.0622x – 2.7868
(r = 0.9984), respectively. All calibration curves were
plotted based on linear regression analysis of the inte-
grated peak area (y) versus concentration (x, μg/mL)
of the four reference standards (caffeoylquinic acid,
aurantiamarin, arctium lappa glycoside and forsythin)
in the standard solution at six different concentra-
tions. The intra-day precision was evaluated by
determining the activity of the standard solutions of
the four compounds under the optimized conditions
five times within 1 day, with relative standard devia-
tions (RSDs) at 1.1–2.1%. The repeatability was also
good, with RSDs ranging from 1.9% to 2.9%, and the
stock solutions of the four compounds were stable at
room temperature for 0–24 hours with RSDs ranging
from 1.9% to 3.0%. The recovery of the four com-
pounds was assessed in six replicates and showed
good accuracy with RSD values of <1.72% for the
range of 90.0–102.6%.
Determination of the content of four active
components in YQS extracts
The content of caffeoylquinic acid, arctium lappa gly-
coside, aurantiamarin, and forsythin differed according
to the extraction methods. The content of caffeoylquinic
acid was greatest in the 30% ethanol extract, while con-
tent of aurantiamarin was greatest in the 95% ethanol
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extract. The content of arctium lappa glycoside was
greatest in water, while the content of forsythin was
greatest in the 70% ethanol extract (Table 1).
EID50 and TD0
The EID50 of IAV was 10–7.25 according to the Kärbe for-
mula. All embryonated chicken eggs were alive when
incubated with the stock solution of YQS, which means
the maximum TD0 of YQS was 500 mg/mL. For com-
parison, the maximum TD0 of ribavirin was
100 mg/mL.
Maximum non-blood clotting
concentration
The maximum non-blood clotting concentration of
the five YQS extracts is shown in Table 2. The concen-
tration used in the later studies was the lower one,
which would not cause hemagglutination. Therefore,
the initial concentration used for this test was 2 × 10–4
(31.3 mg/mL).
Time-dependent IAV-inhibitory effects of
five YQS extracts in vitro
As shown in Table 3, all five extracts inhibited IAV
with onset of action ranging from 1 hour to 24 hours.
Table 1. Relative content of the four active components
of Yinqiaosan in five solvent extracts*
Extract solvent CAA AUR ALG FOR
Water 2.900 0.045 34.347 0.200
30% ethanol 4.472 0.088 18.748 0.282
50% ethanol 3.481 0.073 30.597 0.260
70% ethanol 2.639 0.061 27.832 0.412
95% ethanol 2.541 0.982 21.020 0.229
*Data presented as %. CAA = Caffeoylquinic acid; AUR = auran-
tiamarin; ALG = arctium lappa glycoside; FOR = forsythin.
Table 2. Maximum non-blood clotting concentration of
five solvent extracts of Yinqiaosan
Solvent extract
Dilution Concentration 
ratio (mg/mL)
Water 2 × 10–3 62.5
30% ethanol 2 × 10–3 62.5
50% ethanol 2 × 10–4 31.3
70% ethanol 2 × 10–3 62.5
95% ethanol 2 × 10–4 31.3
The maximum non-blood clotting concentration
(31.3 mg/mL) inhibited IAV proliferation at each time
to different degrees, and the inhibitory effects greatest
between 6–12 hours, and then tapered after 18 hours.
The IAV-inhibitory effect of the 50% ethanol extract
was very significant at each time, particularly at 12
hours (the virus titers in virus group was 1/320 com-
pared with the 50% YQS extract group was 1/10), with
the influenza virus-inhibitory effect to 32 multiples.
Therapeutic effect of YQS extracts on 
IAV-infected embryonated chicken eggs
As summarized in Table 4, there were significant dif-
ferences (p < 0.05) between each extract (water, 30%,
50%, 70%, and 95% ethanol) and each concentration
(500, 250 and 125 mg/mL) versus the IAV group. This
means that each solvent extract with different con-
centration were all effective in IAV-inhibitory on the
embryonated chicken eggs. Of interest, the 50% eth-
anol extract at concentrations of 500 mg/mL and
250mg/mL was superior to ribavirin (p<0.05). Thus,
the 50% ethanol extract may be the optimal extract of
YQS to inhibit IAV in vitro, and should serve as a base-
line for in vivo experiments of YQS for the treatment of
viral infection.
Table 3. Hemagglutination titers of five solvent extracts of Yinqiaosan
Group
Hemagglutination titer
1 hr 6 hr 12 hr 18 hr 24 hr
NaCl – – – – –
IAV 1:320 1:320 1:320 1:320 1:240
Ribavirin 1:40 1:40 1:10 1:30 1:10
YQS extract
Water 1:80 1:40 1:60 1:80 1:60
30% ethanol 1:80 1:40 1:40 1:60 1:80
50% ethanol 1:40 1:20 1:10 1:30 1:40
70% ethanol 1:60 1:60 1:40 1:60 1:80
95% ethanol 1:80 1:40 1:60 1:40 1:80
IAV = Influenza-A virus; YQS = Yinqiaosan.
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DISCUSSION
Optimization of the HPLC conditions
To achieve good separation, we investigated a range
of HPLC analytical parameters including the separa-
tion column, mobile phase and elution mode. The
separation of each chromatographic peak was not op-
timal using a Phenomsil ODS C18 column (150 ×
4.6 mm; i.d., 5 μm). Therefore, we first used gradient
elution modes with methanol/water, acetonitrile/
water and acetonitrile/methanol/water containing
different concentrations of acetic acid for the mobile
phase. We found that the four compounds showed
markedly different polarities, and they did not sepa-
rate well using isocratic and gradient elution. We next
tested different concentrations of methanol and aque-
ous phosphoric acid. However, the chromatographic
peaks split when the phosphoric acid concentration
was lower than 0.4%. Finally, we found that the sepa-
ration was improved using a Phenomsil ODS C18
column (250 × 4.6 mm; i.d., 5 μm) using a solvent sys-
tem composed of methanol (M)/water containing
Table 4. Hemagglutination titer of therapeutic action of
Yinqiaosan extracts with five solvents to influenza-A
virus-infected embryonated hen eggs (n = 8 per group)
Concentration
Hemagglutination 
Group titer (therapeutic 
(mg/mL)
action)
NaCl –
IAV 2.768 ± 0.106*†
Ribavirin 100 0.675 ± 0.437*‡
YQS extracts
Water 500 0.750 ± 0.116*‡§
250 0.675 ± 0.137*‡§
125 0.575 ± 0.225*‡§
30% ethanol 500 0.675 ± 0.437*‡§
250 0.976 ± 0.144*‡§
125 0.976 ± 0.244*‡§
50% ethanol 500 0.175 ± 0.324*‡§¶
250 0.262 ± 0.362*‡§
125 0.850 ± 0.279*†‡¶
70% ethanol 500 1.301 ± 0.228*†‡
250 1.376 ± 0.176*†‡
125 1.527 ± 0.351*†‡
95% ethanol 500 1.753 ± 0.161*†‡
250 1.753 ± 0.161*†‡
125 2.054 ± 0.161*†‡
*p < 0.05 versus NaCl; †p > 0.05 versus ribavirin; ‡p < 0.05 versus
IV; §p < 0.05 versus ribavirin; p > 0.05 versus each YQS extract;
¶p < 0.05 versus each YQS extract. IAV = Influenza-A virus;
YQS = Yinqiaosan.
0.4% phosphoric acid solution (P) as the mobile phase
in a gradient elution mode. Because all of the com-
pounds could be detected using this approach and
with adequate adsorption, the detection wavelength
was set at 275 nm. Under these conditions, the chro-
matograms of the four references compounds and
YQS extracted with water, and 30%, 50%, 70%, or 95%
ethanol are shown in Figures 1 and 2.
Relationship between the fingerprints of
each extract and IAV-inhibitory effects
In this study, we focused on the characterization of the
four main active ingredients of YQS in different solvent
extracts. Figure 1 shows typical chromatograms for
the four reference compounds, and Figure 2 shows
the chromatograms for the four components of YQS
in the five solvent extracts. The retention times of caf-
feoylquinic acid, arctium lappa glycoside, aurantia-
marin, and forsythin were approximately 24.6 minutes,
35.9 minutes, 40.2 minutes, and 41.7 minutes, respec-
tively, and the total chromatographic run-time was
60 minutes. There was a wide variation in the content
of the four components between the five extracts. The
content of caffeoylquinic acid was greatest in the 30%
ethanol extract, while content of aurantiamarin was
greatest in the 95% ethanol extract. The content of
arctium lappa glycoside was greatest in the water
extract, while the content of forsythin was greatest in
the 70% ethanol extract. However, the IAV-inhibitory
effect of YQS was greatest with the 50% ethanol extract,
which indicates that these affects are achieved through
synergistic activity of all of the components rather
than an individual component.
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Figure 1. High-performance liquid chromatography chromato-
gram of the four reference compounds. CAA = Caffeoylquinic acid;
AUR = aurantiamarin; ALG = arctium lappa glycoside; FOR =
forsythin.
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This study differs from previous studies that
investigated the anti-viral effects of YQS. Reference
documentation on the molecular fingerprints of TCM
formulae are still relatively scarce, including for YQS.
Shiyue et al focused on the effective parts in each herb
against influenza virus and the chemical constituents
of YQS, including the isolation of flavonoid and its rel-
ative content [17,18,24]. In our study, our evaluation of
YQS were based on its use in clinical practice, consider-
ing the mechanism and curative effects of the YQS for-
mula rather than individual herbs or specific active
components. We also evaluated how the fingerprint of
YQS was related to its IAV-inhibitory effects, and it was
proposed on the base of effective single component
after component identification. Quality control of the
formulation is closely related to its pharmacody-
namic action, which is very important in terms of
maintaining the quality of medicines, to enhance the
effects of the formulation, and to modernize TCM.
Some of the chromatographic peaks changed when
YQS was extracted using different solvents. For exam-
ple, a chromatographic peak at the retention time of
13 minutes was prominent in the 95% ethanol extract
but was not well defined in the other extracts (Figure 2).
Thus, it seems that some components show solvent
specificity. Although this peak was not a focus of the
present study, it should be considered in future studies.
Rational for determining the maximum
non-blood clotting concentration
In this experiment, some YQS extracts above a certain
concentration caused agglutination of chicken blood
cells, which aroused our attention. Was this phenom-
enon caused by a physical or a chemical reason? If it
was a chemical effect, YQS may contain a component
that could cause chicken red blood cell agglutination.
For this reason, we determined the maximum non-
blood clotting concentration of YQS. Based on a liter-
ature review, it seemed likely that this component was
a lectin. Indeed, there are almost 1,000 types of plant
lectins, which are widely distributed in groups such
as Leguminosae, Solanaceae, Euphorbiaceae, Gramineae,
Liliaceae, and Amaryllidaceae. Legume lectin is the most
abundant, with more than 600 varieties. Several recent
studies have shown that several plants used in TCM,
including Radix isatidis, Ramulus visci, and Aloe, contain
lectins. It has been reported that lectins can promote
lymphocyte proliferation in mice and suppress the
CAA
0
0 10 20 30 40 60
Time (min)
50
100
150
200
250
300
mAU
AUR
ALG
FOR
50
A
CAA
0
0 10 20 30 40 60
Time (min)
50
100
150
200
250
mAU
AUR
ALG
FOR
50
B
C
CAA
0
0 10 20 30 40 60
Time (min)
50
100
150
200
250
300
mAU
AUR
ALG
FOR
50
D
CAA
0
0 10 20 30 40 60
Time (min)
50
100
150
200
250
mAU
AUR
ALG
FOR
50
CAA
0
0 10 20 30 40 60
Time (min)
100
200
300
500
mAU
AUR ALG FOR
50
400
E
Figure 2. High-performance liquid chromatography chro-
matograms of the four components for Yinqiaosan extracted in
(A) water, (B) 30% ethanol, (C) 50% ethanol, (D) 70% ethanol,
and (E) 95% ethanol. CAA = Caffeoylquinic acid; AUR = auran-
tiamarin; ALG = arctium lappa glycoside; FOR = forsythin.
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propagation of tumor cells [25–28]. In pilot studies, we
commonly found chicken red blood cell agglutination,
which prompted our suspicion that the YQS extracts
also contain lectin components, although whether this
is derived from a single or several herbs is unclear.
Therefore, we used the maximum non-blood clotting
concentration to ensure that the extract itself did not
cause agglutination of the chicken blood cell and 
ensure the findings only reflected the direct effects 
of YQS extracts on IAV inhibition.
Assessment of IAV inhibition
The hemagglutination titer was determined to reflect
the effect of YQS extracts on IAV activity. Microscopic
and other quantitative method could also be applied
in future studies to evaluate the relationship between
the fingerprints of the YQS extracts and IAV-inhibitory
effects. Of interest, the therapeutic effect of the 50%
ethanol extract of YQS at concentrations of 500mg/mL
and 250 mg/mL was superior to that of ribavirin.
However, the toxicity of YQS formulations has not
been reported and needs further research.
In conclusion, we used a simple quantitative
method based on HPLC to analysis the relative con-
tent of the four main active components of YQS. The
method offered good linearity, precision, repeatabil-
ity, stability, and recovery. Using this method, we
successfully established the HPLC fingerprints of the
four components in YQS in five solvent extracts. The
study also indicated the possibility that the five sol-
vent extracts of YQS can inhibit IAV in embryonated
eggs in vitro. YQS extracted in 50% ethanol yielded the
greatest effect and was superior to ribavarin. Taken
together, the results of this study provide valuable
evidence supporting the clinical use of YQS.
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不同提取溶劑下銀翹散中四種成分指紋圖譜的建立
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採用高效液相色譜法同時測定不同提取溶劑（水提、30% 醇提、50% 醇提、70% 醇
提、95% 醇提）下銀翹散中綠原酸、橙皮苷、牛蒡苷和連翹苷四種有效成分的含量。
結果顯示上述四種有效成分在 0.93–151.5 mg/L範圍內呈線性關系（R
2
 > 0.9983）;
平均回收率為 91.3 – 100.5%, RSD = 1.89%。並較好的建立了不同溶劑提取下的銀
翹散中四種活性成分的指紋圖譜。本次研究還採用體外直接抑制流感病毒和雞胚抗病
毒實驗技術觀察不同提取工藝銀翹散抗流感病毒療效。結果顯示 50% 醇提法的銀翹
散提取物在 500 mg/mL 和 250 mg/mL 濃度時，其抗流感病毒作用最強，治療效果
優於利巴韋林對照組（p < 0.05）。因此 50% 醇提法可能為銀翹散抗 IV 最佳提取工
藝。該實驗結果表明銀翹散提取物顯示出了較好的體外抗流感病毒作用，為銀翹散以
後用於流感治療的可能性作出了評價。
關鍵詞：指紋圖譜，A型流感病毒，銀翹散 
（高雄醫誌 2010;26:182–91）
